Synlogic reports third quarter 2020 financial results and provides business update

Cambridge, mass., nov. 5, 2020 /prnewswire/ -- synlogic, inc. (nasdaq: sybx), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today reported financial results for the third quarter ended sept. 30, 2020, and provided an update on programs...

SYBX Ratings Summary

SYBX Quant Ranking